CC - Company ID 0001627223
The table below shows Chemours Co's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Revenue | $1.38B | $1.33B | $1.50B | $1.61B | $1.37B | $1.36B |
| Cost of revenue | $1.17B | $1.17B | $1.26B | $1.34B | $1.13B | $1.09B |
| Gross profit | $212.00M | - | $233.00M | $278.00M | $236.00M | $265.00M |
| R&D | $26.00M | - | $26.00M | $28.00M | $27.00M | - |
Chemours Co reported annual revenue of $5.81B for fiscal year 2025. That is up 0.4% from $5.78B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $5.40B (FY 2016) to $5.81B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $147.00M | - | $122.00M | $424.00M | $123.00M | - |
| Operating income | - | - | - | - | - | - |
| Income tax | $7.00M | - | -$8.00M | $131.00M | $5.00M | $12.00M |
| Net income | -$29.00M | -$47.00M | $46.00M | -$380.00M | -$5.00M | -$11.00M |
| EPS (diluted) | -$0.19 | -$0.31 | $0.31 | -$2.53 | -$0.03 | -$0.08 |